drugset / Trial / NCT00566124
Basal Insulins - Pharmacodynamics
Phase 4
Completed
10 enrolled
University of Aarhus
Novo Nordisk A/S · collabThe Danish Diabetes Association · collabThe Institute of Experimental Clinical Research, University of Aarhus · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
Timeline
- Start
- 2005-01
- Primary completion
- —
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulatard | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |
| Comparator | insulin detemir | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |
| Comparator | insulin glargine | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |